Historical record - last NADAC publication: 4/18/2013
Product Information
CYCLOPHOSPHAMIDE 500 MG VIAL is a generic product labeled by Baxter Healthcare Corporation, priced at $227.7200 per EA under NDC 10019095501. Its NADAC has been published 17 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the cyclophosphamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/25mL
Manufacturer
Baxter Healthcare CorporationNDC
10019095501
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS; ORAL
Last Updated
4/18/2013
Active Ingredients
CYCLOPHOSPHAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040745On Market Since
5/21/2008
Price Statistics
The NADAC for CYCLOPHOSPHAMIDE 500 MG VIAL has been published 17 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $227.7200 per EA |
|---|---|
| All-time high | $227.7200 (Mar 19, 2014) |
| All-time low | $227.7200 (Nov 28, 2013) |
| Median price | $227.7200 |
| Average price | $227.7200 |
| Largest weekly change | 0.0% (Dec 5, 2013) |
| Weeks tracked | 17 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the cyclophosphamide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CYCLOPHOSPHAMIDE 500 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOPHOSPHAMIDE 500 MG VIAL, manufactured by Baxter Healthcare Corporation, is $227.7200 per EA (NDC 10019095501), effective Mar 19, 2014.
How has the price of CYCLOPHOSPHAMIDE 500 MG VIAL changed over time?
Over the history we have for it, the NADAC for CYCLOPHOSPHAMIDE 500 MG VIAL has held within roughly two percent of its current level. It has been tracked across 17 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CYCLOPHOSPHAMIDE 500 MG VIAL?
Since Nov 28, 2013, the NADAC for CYCLOPHOSPHAMIDE 500 MG VIAL has ranged from a low of $227.7200 (Nov 28, 2013) to a high of $227.7200 (Mar 19, 2014), with a median of $227.7200 per EA.
Are there cheaper alternatives to CYCLOPHOSPHAMIDE 500 MG VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CYCLOPHOSPHAMIDE 500 MG VIAL, so no direct lower-cost alternative is listed.
Who manufactures CYCLOPHOSPHAMIDE 500 MG VIAL?
CYCLOPHOSPHAMIDE 500 MG VIAL (NDC 10019095501) is labeled by Baxter Healthcare Corporation, and CMS classifies it as a generic product.
Related Drugs
Same classification